207 related articles for article (PubMed ID: 2413458)
1. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.
Scheefers-Borchel U; Müller-Berghaus G; Fuhge P; Eberle R; Heimburger N
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7091-5. PubMed ID: 2413458
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
4. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
5. The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.
Schielen WJ; Voskuilen M; Tesser GI; Nieuwenhuizen W
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8951-4. PubMed ID: 2813432
[TBL] [Abstract][Full Text] [Related]
6. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
7. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
Hui KY; Haber E; Matsueda GR
Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin.
Haidaris PJ; Peerschke EI; Marder VJ; Francis CW
Blood; 1989 Nov; 74(7):2437-44. PubMed ID: 2478231
[TBL] [Abstract][Full Text] [Related]
11. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen.
Hui KY; Haber E; Matsueda GR
Science; 1983 Dec; 222(4628):1129-32. PubMed ID: 6648524
[TBL] [Abstract][Full Text] [Related]
13. Accessibility of epitopes on fibrin clots and fibrinogen gels.
Procyk R; Kudryk B; Callender S; Blombäck B
Blood; 1991 Apr; 77(7):1469-75. PubMed ID: 1706954
[TBL] [Abstract][Full Text] [Related]
14. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.
Lill H; Spannagl M; Trauner A; Schramm W; Schuller D; Ofenloch-Haehnle B; Draeger B; Naser W; Dessauer A
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):97-102. PubMed ID: 8457660
[TBL] [Abstract][Full Text] [Related]
15. Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites.
Pacella BL; Hui KY; Haber E; Matsueda GR
Mol Immunol; 1983 May; 20(5):521-7. PubMed ID: 6348513
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for a conformationally altered state of fibrinogen.
Zamarron C; Ginsberg MH; Plow EF
Thromb Haemost; 1990 Aug; 64(1):41-6. PubMed ID: 1703332
[TBL] [Abstract][Full Text] [Related]
17. The sequence gamma-(312-324) is a fibrin-specific epitope.
Schielen WJ; Adams HP; van Leuven K; Voskuilen M; Tesser GI; Nieuwenhuizen W
Blood; 1991 May; 77(10):2169-73. PubMed ID: 1709373
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the species selectivity of a fibrin-specific monoclonal antibody.
Matsueda GR; Margolies MN
Biochemistry; 1986 Mar; 25(6):1451-5. PubMed ID: 2421767
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
[TBL] [Abstract][Full Text] [Related]
20. Use of synthetic peptides to produce a variety of fibrin antibodies.
McCallion D; Stirk CM; McNally S; Thompson WD; Melvin WT
Biochem Soc Trans; 1996 May; 24(2):285S. PubMed ID: 8736943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
